The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(Cyclopentylamino)-9-methyl-8-(pyridin-3-yl)-9H-purine ID: ALA4176479
PubChem CID: 11680901
Max Phase: Preclinical
Molecular Formula: C16H18N6
Molecular Weight: 294.36
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1c(-c2cccnc2)nc2c(NC3CCCC3)ncnc21
Standard InChI: InChI=1S/C16H18N6/c1-22-15(11-5-4-8-17-9-11)21-13-14(18-10-19-16(13)22)20-12-6-2-3-7-12/h4-5,8-10,12H,2-3,6-7H2,1H3,(H,18,19,20)
Standard InChI Key: KDIBHOZUSSKCMY-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
14.1178 -4.5317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1167 -5.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8247 -5.7602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8229 -4.1228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5316 -4.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5318 -5.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3148 -5.6054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7985 -4.9393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3144 -4.2735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6125 -4.9376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0207 -5.6468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8371 -5.6468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2463 -4.9384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8331 -4.2285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0180 -4.2319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8205 -3.3056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5675 -6.3825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1116 -2.8991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0263 -2.0871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2265 -1.9196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8200 -2.6285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3687 -3.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 10 1 0
4 16 1 0
7 17 1 0
16 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 294.36Molecular Weight (Monoisotopic): 294.1593AlogP: 2.78#Rotatable Bonds: 3Polar Surface Area: 68.52Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.34CX LogP: 2.16CX LogD: 2.16Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.80Np Likeness Score: -1.20
References 1. Lambertucci C, Marucci G, Dal Ben D, Buccioni M, Spinaci A, Kachler S, Klotz KN, Volpini R.. (2018) New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases., 151 [PMID:29614417 ] [10.1016/j.ejmech.2018.03.067 ]